Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS managers praise Blair’s record

May 10, 2007

News of Tony Blair's resignation as Prime Minister has been greeted with a tribute from NHS managers.Blair has announced he …

News

NICE attacks ‘flawed and inaccurate’ cancer report

May 10, 2007

Andrew Dillon, the chief executive of NICE has hit out at a new report which says the UK has the …

News

Leapfrog leads Adventis’ online drive

May 10, 2007
Medical Communications digi

Leapfrog has expanded its multimedia division as part of an investment drive into cutting-edge technologies by its parent company, marketing …

News

Novartis buys rights to smoking vaccine

May 10, 2007
Research and Development, Sales and Marketing

Smokers who are addicted to the nicotine in their daily cigarettes could soon receive a vaccine to help them kick …

News

AstraZeneca’s latest purchase fails to impress investors

May 10, 2007
Research and Development, Sales and Marketing

AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the $15.6 billion …

News

The End of the Junket?

May 10, 2007
Medical Communications, Sales and Marketing ethics

Once considered a perk of the job by some doctors, trips to glamorous locations paid for by pharma companies are …

News

Scottish Sprycel approval turns spotlight on NICE

May 9, 2007
Sales and Marketing Scotland

The Scottish Medicines Consortium has approved BMS leukaemia drug Sprycel, but patients in England could face a substantial wait for …

News

Take NHS away from politicians, say doctors

May 9, 2007

Doctors have put together a list of radical reforms they say will stop the government undermining the NHS in England …

News

Product news roundup from Datamonitor

May 9, 2007
Research and Development, Sales and Marketing

Additional indication for Pfizer's FragminThe FDA has approved a new indication for blood clot drug Fragmin to treat symptomatic venous …

News

Training marketers in the gentle art of teamwork

May 8, 2007
Business Services recruitment, training

Feature

EMEA gives extension to Celebrex’s European arthritis licence

May 4, 2007
Sales and Marketing

Pfizer's Celebrex has received European approval for a new indication to treat arthritis pain and inflammation.The company will look to …

News

NHS must prepare for health impact of global warming, say experts

May 4, 2007
Sales and Marketing

The British public and the NHS need to adapt to climate change and the new risks to health it will …

News

Herceptin approved for new breast cancer combination

May 4, 2007
Sales and Marketing

Herceptin has gained approval in Europe for use in combination with aromatase inhibitor drugs.Herceptin and aromatase inhibitors each block hormones …

News

Generic attacks dent Sanofi-Aventis

May 4, 2007
Sales and Marketing generics

Some of Sanofi-Aventis' biggest selling drugs came under assault from generic competitors in the first part of 2007, holding back …

News

Animal rights extremists arrested in nationwide raids

May 2, 2007
Sales and Marketing animal activists

More than 30 suspected animal rights extremists have been arrested in raids across the UK and Europe in one of …

News

News update from Datamonitor

May 1, 2007
Research and Development, Sales and Marketing

Common pain medications do not prevent Alzheimer's diseaseOver-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's …

News

Industry lobbies ministers ahead of OFT decision

May 1, 2007
Sales and Marketing

The UK pharmaceutical industry is using a series of meetings with government ministers to push for a rejection of the …

News

Can pharma meet the generic challenge?

May 1, 2007
Sales and Marketing generics, pharma, sales

The global pharmaceutical industry has generally been seen as one of the most successful industries in delivering revenue growth with …

Feature

Pharma news from Datamonitor

April 26, 2007
Research and Development, Sales and Marketing

Gemin X compound effective in leukemiaGemin X has said its compound that treats acute lymphoblastic leukemia produced positive results in …

News

Product update from Datamonitor

April 26, 2007
Research and Development, Sales and Marketing

Schering-Plough receives Japanese approval for ZetiaSchering-Plough has received Japanese marketing approval for Zetia, a cholesterol-lowering agent that inhibits the absorption …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026